Nanosilica carrier with spions and a curcuminoid
Silica nanocarriers hybridized with superparamagnetic iron oxide nanoparticles (“SPIONs”) and curcumin through equilibrium or enforced adsorption technique. Methods for dual delivery of SPIONs and curcumin to a target for diagnosis or therapy, for example, for SPION-based magnetic resonance imaging or for targeted delivery of curcumin to a cell or tissue. The technique can be extend to co-precipitation of mixed metal oxide involving Ni, Mn, Co and Cu oxide. The calcination temperature can be varied from 500-900° C. The nanocombination is functionalized with chitosan, polyacrylic acid, PLGA or another agent to increase its biocompatibility in vivo.
1. A method for making a silica nanocarrier comprising superparamagnetic iron oxide nanoparticles (SPIONs) and curcumin, comprising:
impregnating nanostructured pore surfaces of a platform of nanoporous structured silica with SPIONs to form an impregnated platform of structured silica,
calcining the impregnated platform of structured silica between 500 and 900° C. to form a calcined platform of structured silica, and
adsorbing a curcuminoid onto the calcined platform of structure silica and magnetic nanoparticles to form the silica nanocarrier,
wherein the silica nanocarrier comprises
a platform of nanoporous structured silica selected from the group consisting of SiSBA-16, Q-10 silica, mesocellular foam, silicalite, mesosilicalite, SiKIT-6, ULPFDU-12, SiMCM-41, ZSM-5, USY, Mordenite, ZSM-11, ZSM-12, ZSM-22, ZSM-23, mesocarbon, graphene oxide and mixtures thereof,
wherein the superparamagnetic iron oxide nanoparticles (SPIONS) are present in an amount ranging from about 5 wt % to about 30 wt % based on total weight of the silica nanocarrier, and
wherein the curcuminoid is adsorbed on the surface of the nanoporous structured silica.
2. The method of claim 1 , wherein the platform of nanoporous structured silica comprises MSU-foam.
3. The method of claim 1 , wherein the platform of nanoporous structured silica comprises SiSBA-16.
4. The method of claim 1 , wherein the platform of nanoporous structured silica comprises Q-10.
5. The method of claim 1 , wherein the SPIONs comprise Fe 2 O 3 or a mixture of NiFe 2 O 4 , CuFe 2 O 4 , MnFe 2 O 4 or CoFe 2 O 4 .
6. The method of claim 1 , wherein the SPIONs comprise γ-Fe 2 O 3 .
7. The method of claim 1 , wherein the SPIONs have an average particle size ranging from about 7 to about 18 nm when the platform of nanoporous structured silica is MSU-foam, about 9 to 21 nm when the platform of nanoporous structured silica is SiSBA-16; or about 10 to about 25 nm when the platform of nanoporous structured silica is Q-10.
8. The method of claim 1 , wherein the curcuminoid is present in an amount ranging from 50 to 70 wt %.
9. The method of claim 1 , wherein the silica nanocarrier further comprises a polymer, wherein the SPIONs and/or the curcuminoid is covered with or incorporated into the polymer; and/or wherein one or more components of the composition is functionalized with chitosan, polyacrylic acid, PLGA, or another agent to increase its biocompatibility in vivo.
10. The method of claim 1 , wherein the silica nanocarrier further comprises at least one antibody or other targeting agent that binds to cancer cells, neoplasm cells, or tumor cells.
11. The method of claim 1 , wherein the silica nanocarrier has a degree of magnetization (M, emu/g) as measured by vibrating sample magnetometry (VSM) greater than an otherwise identical composition wherein the platform of nanoporous structured silica consists of SiSBA-16, Q-10 silica, mesocellular foam, silicalite, mesosilicalite, SiKIT-6, ULPFDU-12 or SiMCM-41.
12. The method of claim 1 , wherein the silica nanocarrier has a percentage of cumulative curcuminoid release, in phosphate buffered saline (PBS) at pH 5.6 and 37° C. over 72 hours, greater than an otherwise identical composition wherein the platform of nanoporous structured silica consists of SiSBA-16, Q-10 silica, mesocellular foam, silicalite, mesosilicalite, SiKIT-6, ULPFDU-12 or SIMCM-41.
13. The method of claim 1 , wherein the platform of nanoporous structured silica is at least one of MSU-foam SiSBA-16, or Q-10; and the curcuminoid is curcumin which is adsorbed through an equilibrium or enforced adsorption technique.